Use of the combination of teriflunomide and glatiramer acetate for treating multiple sclerosis

Details for Australian Patent Application No. 2010308364 (hide)

Owner Sanofi-Aventis U.S. LLC

Inventors Byrnes, William; Douillet, Patrice; Frangin, Gerald

Agent Watermark

Pub. Number AU-A-2010308364

PCT Pub. Number WO2011/049792

Priority 09306036.6 29.10.09 EP; 09305999.6 22.10.09 EP; 61/286,153 14.12.09 US; 61/261,954 17.11.09 US

Filing date 13 October 2010

Wipo publication date 28 April 2011

International Classifications

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61K 31/277 (2006.01)

A61K 31/785 (2006.01)

Event Publications

3 May 2012 PCT application entered the National Phase

  PCT publication WO2011/049792 Priority application(s): WO2011/049792

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010308366-Extra-articular implantable mechanical energy absorbing assemblies having a tension member and methods

2010308353-System and method for demosaicing image data using weighted gradients